Ascendis Pharma A (ASND) FCF Margin (2014 - 2026)
Ascendis Pharma A's FCF Margin was 83.02% in the quarter ended Jun 30, 2026, up 87.67 percentage points from -4.64% a year earlier and up 86.15 percentage points from the prior quarter.
Ascendis Pharma A (ASND) FCF Margin (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ascendis Pharma A's FCF Margin was 16.15% through Jun 30, 2026, up 49.59 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at -17.47%, up 57.99 percentage points from the prior year.
- FCF Margin has now increased for four consecutive years, with a five-year change of +3602.38 percentage points (years ended Dec 2020 to Dec 2025).
- In earlier years, FCF Margin was -75.46% in the year ended Dec 31, 2024 (+99.77 pp), -175.23% in the year ended Dec 31, 2023 (+812.06 pp), -987.29% in the year ended Dec 31, 2022 (+4382.33 pp) and -5369.62% in the year ended Dec 31, 2021 (-1749.77 pp).
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly FCF Margin in data going back to the quarter ended Mar 31, 2014.
- Compared with a year earlier, FCF Margin has increased for six straight quarters, with an average year-over-year change of +73.19 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was the quarter ended Jun 30, 2022 (a gain of 8962.74 percentage points); the worst was the quarter ended Sep 30, 2021 (a drop of 5826.05 percentage points).
- Per Business Quant data, ASND's FCF Margin in the three quarters before the quarter ended Jun 30, 2026 was -3.13% (quarter ended Mar 31, 2026), -42.94% (quarter ended Dec 31, 2025) and 1.01% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.01% |
| 10 | Ascendis Pharma A | 14.48 Bn | 10.74 Bn | 362.22 Mn | 83.02% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.02% |
| Mar 31, 2026 | -3.13% |
| Dec 31, 2025 | 29.66% |
| Sep 30, 2025 | 1.01% |
| Jun 30, 2025 | -4.64% |
| Mar 31, 2025 | -14.18% |
| Dec 31, 2024 | -50.13% |
| Sep 30, 2024 | -97.86% |
| Jun 30, 2024 | -171.26% |
| Mar 31, 2024 | -106.14% |
| Dec 31, 2023 | -30.80% |
| Sep 30, 2023 | -261.68% |
| Jun 30, 2023 | -324.04% |
| Mar 31, 2023 | -441.00% |
| Dec 31, 2022 | -635.34% |
| Sep 30, 2022 | -667.08% |
| Jun 30, 2022 | -2,079.85% |
| Mar 31, 2022 | -1,971.38% |
| Dec 31, 2021 | -2,616.03% |
| Sep 30, 2021 | -9,777.09% |
Ascendis Pharma A FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();